C-Terminal Peptide Modification via Photocatalytic Decarboxylation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for modifying the C-terminal end of peptides are limited in compatibility, particularly with natural peptides and a wide range of cargos, often requiring specific solvents and non-natural chemistry, which restricts their application in sequencing, drug conjugation, and array formation.
Innovation Solution
A method involving a two-stage process where the C-terminal end of a peptide is decarboxylated using a specific catalyst and radiation, followed by exposure to a second reactant to introduce a bis(2-sulfanylacyl)amido functional group, allowing for the attachment of a variety of cargos, including peptides, antibodies, and drugs, compatible with most peptide residues and solvents like DMSO or water.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If prior art methods for C-terminal peptide modification are used, then modification can be achieved, but compatibility with natural peptides and a wide range of cargos is limited
Solution Approach 1:
The patent changes the chemical parameters of the modification method by using a photo-induced decarboxylation reaction with a specific catalyst system (IrIII or RuII complex with bipyridine ligand) that works under visible light irradiation. This enables C-terminal modification of natural peptides without requiring non-natural amino acids or specialized solvents, thereby improving compatibility while maintaining ease of manufacture
Solution Approach 2:
The patent replaces traditional chemical coupling methods (which require specific solvents and activation chemistry) with a photo-induced radical mechanism. The visible light irradiation initiates decarboxylation to generate a carbon-centered radical at the C-terminus, which then reacts with various cargos. This substitution of chemical activation with photochemical activation broadens substrate compatibility while simplifying reaction conditions
2Adaptability or versatility
If solid phase synthesis methods are used for C-terminal modification, then modification can be achieved, but the method becomes restricted and less versatile
Solution Approach 1:
The patent extracts the modification reaction from the solid phase synthesis context and performs it in solution phase. The peptide remains in its native soluble state throughout the reaction, eliminating the need for solid support resins, filtration steps, and specialized solid phase equipment. This extraction enables broader applicability to different peptide and cargo combinations while reducing methodological complexity
Solution Approach 2:
The patent introduces a small molecule carboxylic acid derivative as an intermediary that undergoes photo-induced decarboxylation to generate the reactive radical species. This intermediary mediates between the peptide substrate and various cargo molecules, enabling versatile coupling without requiring direct activation of the peptide C-terminus or solid phase conditions
3Adaptability or versatility
If specific solvents are used for C-terminal modification, then reaction can proceed, but peptides insoluble in such solvents cannot be modified
Solution Approach 1:
The patent changes the solvent system from traditional organic solvents required by prior art methods to aqueous or buffer-based conditions. The photo-induced decarboxylation reaction proceeds efficiently in water or aqueous buffers, enabling modification of peptides and proteins that are insoluble in organic solvents. This parameter change in solvent polarity and composition dramatically expands the range of modifiable substrates
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables selective and versatile C-terminal modification of peptides, facilitating the formation of peptide-cargo conjugates suitable for sequencing, drug delivery, and array construction, with broad compatibility across different peptide residues and solvents.
Implementation Method 1
the first catalyst may be configured to decarboxylate the C-terminal end of the peptide in the presence of the first radiation
Implementation Method 2
reacting the C-terminal end of the peptide with a first reactant in the presence of a first catalyst and first radiation to provide a first intermediate
Implementation Method 3
introduce a reactive group to the C-terminal end of the peptide, especially a bis(2-sulfanylacyl)amido functional group
Implementation Method 4
selectively covalently linked to the C-terminal end of a natural peptide
Data Source
AI summary
The invention provides a method for providing a cargo to a C-terminal end of a peptide, the method comprising a first stage and a second stage, wherein the first stage comprises reacting the C-terminal end of the peptide with a first reactant in the presence of a first catalyst and first radiation to provide a first intermediate, wherein the first catalyst is configured to decarboxylate the C-terminal end of the peptide in the presence of the first radiation; and wherein the second stage comprises exposing the first intermediate to a second reactant.